These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 25156796)

  • 21. Characterization of Redox-Responsive LXR-Activating Nanoparticle Formulations in Primary Mouse Macrophages.
    Smith TKT; Kahiel Z; LeBlond ND; Ghorbani P; Farah E; Al-Awosi R; Cote M; Gadde S; Fullerton MD
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31635211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver X receptor-α and miR-130a-3p regulate expression of sphingosine 1-phosphate receptor 2 in human umbilical vein endothelial cells.
    Fan A; Wang Q; Yuan Y; Cheng J; Chen L; Guo X; Li Q; Chen B; Huang X; Huang Q
    Am J Physiol Cell Physiol; 2016 Feb; 310(3):C216-26. PubMed ID: 26669941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The liver X receptor promotes macrophage differentiation and suppresses osteoclast formation in mouse RAW264.7 promyelocytic leukemia cells exposed to bacterial lipopolysaccharide.
    Robertson Remen KM; Gustafsson JÅ; Andersson G
    Biochem Biophys Res Commun; 2013 Jan; 430(1):375-80. PubMed ID: 23159616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver X Receptor Regulates Triglyceride Absorption Through Intestinal Down-regulation of Scavenger Receptor Class B, Type 1.
    Briand O; Touche V; Colin S; Brufau G; Davalos A; Schonewille M; Bovenga F; Carrière V; de Boer JF; Dugardin C; Riveau B; Clavey V; Tailleux A; Moschetta A; Lasunción MA; Groen AK; Staels B; Lestavel S
    Gastroenterology; 2016 Mar; 150(3):650-8. PubMed ID: 26602218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of sphingomyelin phosphodiesterase acid-like 3A gene (SMPDL3A) by liver X receptors.
    Noto PB; Bukhtiyarov Y; Shi M; McKeever BM; McGeehan GM; Lala DS
    Mol Pharmacol; 2012 Oct; 82(4):719-27. PubMed ID: 22810003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elimination of macrophages drives LXR-induced regression both in initial and advanced stages of atherosclerotic lesion development.
    van der Stoep M; Li Z; Calpe-Berdiel L; van der Sluis RJ; Saleh P; McKinnon HJ; Smit MJ; Korporaal SJ; Van Berkel TJ; Van Eck M; Hoekstra M
    Biochem Pharmacol; 2013 Dec; 86(11):1594-602. PubMed ID: 24095721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of LXRs using the synthetic agonist GW3965 represses the production of pro-inflammatory cytokines by murine mast cells.
    Nunomura S; Okayama Y; Matsumoto K; Hashimoto N; Endo-Umeda K; Terui T; Makishima M; Ra C
    Allergol Int; 2015 Sep; 64 Suppl():S11-7. PubMed ID: 26344074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver X receptor-dependent inhibition of microglial nitric oxide synthase 2.
    Secor McVoy JR; Oughli HA; Oh U
    J Neuroinflammation; 2015 Feb; 12():27. PubMed ID: 25889344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions.
    Laffitte BA; Joseph SB; Chen M; Castrillo A; Repa J; Wilpitz D; Mangelsdorf D; Tontonoz P
    Mol Cell Biol; 2003 Mar; 23(6):2182-91. PubMed ID: 12612088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipidomic analysis of human primary hepatocytes following LXR activation with GW3965 identifies AGXT2L1 as a main target associated to changes in phosphatidylethanolamine.
    Santinha D; Klopot A; Marques I; Ellis E; Jorns C; Johansson H; Melo T; Antonson P; Jakobsson T; Félix V; Gustafsson JÅ; Domingues MR; Mode A; Helguero LA
    J Steroid Biochem Mol Biol; 2020 Apr; 198():105558. PubMed ID: 31783151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of liver X receptor reduces global ischemic brain injury by reduction of nuclear factor-kappaB.
    Cheng O; Ostrowski RP; Liu W; Zhang JH
    Neuroscience; 2010 Apr; 166(4):1101-9. PubMed ID: 20096333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver X receptor agonist GW3965 dose-dependently regulates lps-mediated liver injury and modulates posttranscriptional TNF-alpha production and p38 mitogen-activated protein kinase activation in liver macrophages.
    Wang YY; Dahle MK; Steffensen KR; Reinholt FP; Collins JL; Thiemermann C; Aasen AO; Gustafsson JA; Wang JE
    Shock; 2009 Nov; 32(5):548-53. PubMed ID: 19295476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of Liver X receptors in the heart leads to accumulation of intracellular lipids and attenuation of ischemia-reperfusion injury.
    Lei P; Baysa A; Nebb HI; Valen G; Skomedal T; Osnes JB; Yang Z; Haugen F
    Basic Res Cardiol; 2013 Jan; 108(1):323. PubMed ID: 23266787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver X receptor modulates diabetic retinopathy outcome in a mouse model of streptozotocin-induced diabetes.
    Hazra S; Rasheed A; Bhatwadekar A; Wang X; Shaw LC; Patel M; Caballero S; Magomedova L; Solis N; Yan Y; Wang W; Thinschmidt JS; Verma A; Li Q; Levi M; Cummins CL; Grant MB
    Diabetes; 2012 Dec; 61(12):3270-9. PubMed ID: 22891211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis.
    Beldman TJ; Senders ML; Alaarg A; Pérez-Medina C; Tang J; Zhao Y; Fay F; Deichmöller J; Born B; Desclos E; van der Wel NN; Hoebe RA; Kohen F; Kartvelishvily E; Neeman M; Reiner T; Calcagno C; Fayad ZA; de Winther MPJ; Lutgens E; Mulder WJM; Kluza E
    ACS Nano; 2017 Jun; 11(6):5785-5799. PubMed ID: 28463501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The synthetic liver X receptor agonist GW3965 reduces tissue factor production and inflammatory responses in human islets in vitro.
    Scholz H; Lund T; Dahle MK; Collins JL; Korsgren O; Wang JE; Foss A
    Diabetologia; 2009 Jul; 52(7):1352-62. PubMed ID: 19415233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The medicinal chemistry of liver X receptor (LXR) modulators.
    Tice CM; Noto PB; Fan KY; Zhuang L; Lala DS; Singh SB
    J Med Chem; 2014 Sep; 57(17):7182-205. PubMed ID: 24832115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of liver X receptor (LXR) inhibits receptor activator of nuclear factor κB ligand (RANKL)-induced osteoclast differentiation in an LXRβ-dependent mechanism.
    Remen KM; Henning P; Lerner UH; Gustafsson JÅ; Andersson G
    J Biol Chem; 2011 Sep; 286(38):33084-94. PubMed ID: 21784849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The liver X receptor agonist GW3965 improves recovery from mild repetitive traumatic brain injury in mice partly through apolipoprotein E.
    Namjoshi DR; Martin G; Donkin J; Wilkinson A; Stukas S; Fan J; Carr M; Tabarestani S; Wuerth K; Hancock RE; Wellington CL
    PLoS One; 2013; 8(1):e53529. PubMed ID: 23349715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and pharmacology of 1,1-bistrifluoromethylcarbinol derivatives as liver X receptor β-selective agonists.
    Koura M; Matsuda T; Okuda A; Watanabe Y; Yamaguchi Y; Kurobuchi S; Matsumoto Y; Shibuya K
    Bioorg Med Chem Lett; 2015 Jul; 25(13):2668-74. PubMed ID: 25998501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.